BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8652834)

  • 21. Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
    Innes A; May PC; Pavlů J; Bain BJ
    Am J Hematol; 2012 Apr; 87(4):412. PubMed ID: 21953481
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute leukemia in Jehovah's Witnesses].
    Bueno J; Zuazu J; Villalba T; Julià A
    Sangre (Barc); 1999 Oct; 44(5):381-2. PubMed ID: 10618916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    Dunphy CH; Kitchen S; Saravia O; Velasquez WS
    Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
    Mantadakis E; Danilatou V; Stiakaki E; Paterakis G; Papadhimitriou S; Kalmanti M
    Pediatr Blood Cancer; 2007 Mar; 48(3):354-7. PubMed ID: 16206214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
    Buchanan GR; Rivera GK; Pollock BH; Boyett JM; Chauvenet AR; Wagner H; Maybee DA; Crist WM; Pinkel D
    Cancer; 2000 Mar; 88(5):1166-74. PubMed ID: 10699908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.
    Bowman WP; Larsen EL; Devidas M; Linda SB; Blach L; Carroll AJ; Carroll WL; Pullen DJ; Shuster J; Willman CL; Winick N; Camitta BM; Hunger SP; Borowitz MJ
    Pediatr Blood Cancer; 2011 Oct; 57(4):569-77. PubMed ID: 21360654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
    Kingma A; Van Dommelen RI; Mooyaart EL; Wilmink JT; Deelman BG; Kamps WA
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):106-14. PubMed ID: 11990695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia.
    Minicucci EM; Lopes LF; Crocci AJ
    Leuk Res; 2003 Jan; 27(1):45-50. PubMed ID: 12479851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
    Sandlund JT; Pui CH; Zhou Y; Behm FG; Onciu M; Razzouk BI; Hijiya N; Campana D; Hudson MM; Ribeiro RC
    Leukemia; 2009 Jun; 23(6):1127-30. PubMed ID: 19194463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.
    Lauten M; Möricke A; Beier R; Zimmermann M; Stanulla M; Meissner B; Odenwald E; Attarbaschi A; Niemeyer C; Niggli F; Riehm H; Schrappe M
    Haematologica; 2012 Jul; 97(7):1048-56. PubMed ID: 22271901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.
    Parasole R; Petruzziello F; Menna G; Mangione A; Cianciulli E; Buffardi S; Marchese L; Nastro A; Misuraca A; Poggi V
    Leuk Lymphoma; 2010 Jun; 51(6):1063-71. PubMed ID: 20470218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute lymphoblastic leukemia with t(1;11)(p32;q23) in a patient treated for osteogenic sarcoma.
    Pinto LI; Marczyk FF; Brunetto AL
    Pediatr Hematol Oncol; 1998; 15(1):93-5. PubMed ID: 9509513
    [No Abstract]   [Full Text] [Related]  

  • 33. Late effects of anticancer therapy on kidney function in children with acute lymphoblastic leukemia.
    Kopecna L
    Bratisl Lek Listy; 2001; 102(8):357-60. PubMed ID: 11763664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult acute lymphoblastic leukemia: results of an aggressive regimen in India.
    Raje N; Pai S; Vaidya S; Gopal R; Parikh P; Saikia T; Pai V; Nadkarni K; Advani IM
    Leuk Lymphoma; 1994 Jul; 14(3-4):285-90. PubMed ID: 7950917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
    Sawicka-Zukowska M; Kajdas L; Muszynska-Roslan K; Krawczuk-Rybak M; Sonta-Jakimczyk D; Szczepanski T
    Pediatr Hematol Oncol; 2006 Dec; 23(8):625-9. PubMed ID: 17065138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial.
    Horibe K; Yumura-Yagi K; Kudoh T; Nishimura S; Oda M; Yoshida M; Komada Y; Hara J; Tawa A; Usami I; Tanizawa A; Kato K; Kobayashi R; Matsuo K; Hori H;
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):81-89. PubMed ID: 28169879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia.
    Yetgin S; Cetin M
    Leuk Lymphoma; 2003 Mar; 44(3):489-95. PubMed ID: 12688320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group.
    Kobayashi T; Tobinai K; Shimoyama M; Mikuni C; Konda S; Kozuru M; Araki K; Sai T; Fukuhara S; Matsumoto M; Aoki I; Deura K; Oyama A; Hotta T; Abe T; Toki H; Nagai M; Fukuda H; Niimi M; Yamaguchi N; Tajima K; Shirakawa S
    Jpn J Clin Oncol; 1999 Jul; 29(7):340-8. PubMed ID: 10470659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
    Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurological complications during treatment of childhood cancer: mind Wernicke encephalopathy.
    La Spina M; Catania R; Lo Nigro L; De Grandi C; Palmucci S; Di Cataldo A
    Pediatr Hematol Oncol; 2010 May; 27(4):320-3. PubMed ID: 20426524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.